324 related articles for article (PubMed ID: 27849623)
1. Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation.
Ozsu E; Giri D; Seymen Karabulut G; Senniappan S
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1403-1406. PubMed ID: 27849623
[TBL] [Abstract][Full Text] [Related]
2. Molecular and clinical features of K
Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
[TBL] [Abstract][Full Text] [Related]
3. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
[TBL] [Abstract][Full Text] [Related]
4. Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation.
Peña-Almazan S
Diabetes Res Clin Pract; 2015 Apr; 108(1):e18-20. PubMed ID: 25678012
[TBL] [Abstract][Full Text] [Related]
5. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
[TBL] [Abstract][Full Text] [Related]
6. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
Zhang M; Chen X; Shen S; Li T; Chen L; Hu M; Cao L; Cheng R; Zhao Z; Luo F
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):877-84. PubMed ID: 25781672
[TBL] [Abstract][Full Text] [Related]
7. Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene.
Doneray H; Houghton J; Tekgunduz KS; Balkir F; Caner I
J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):367-71. PubMed ID: 24150202
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
Shimomura K; Hörster F; de Wet H; Flanagan SE; Ellard S; Hattersley AT; Wolf NI; Ashcroft F; Ebinger F
Neurology; 2007 Sep; 69(13):1342-9. PubMed ID: 17652641
[TBL] [Abstract][Full Text] [Related]
9. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
Mohamadi A; Clark LM; Lipkin PH; Mahone EM; Wodka EL; Plotnick LP
Pediatr Diabetes; 2010 May; 11(3):203-7. PubMed ID: 19686306
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype correlation of K
Gopi S; Kavitha B; Kanthimathi S; Kannan A; Kumar R; Joshi R; Kanodia S; Arya AD; Pendsey S; Pendsey S; Raghupathy P; Mohan V; Radha V
Pediatr Diabetes; 2021 Feb; 22(1):82-92. PubMed ID: 32893419
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.
Stanik J; Gasperikova D; Paskova M; Barak L; Javorkova J; Jancova E; Ciljakova M; Hlava P; Michalek J; Flanagan SE; Pearson E; Hattersley AT; Ellard S; Klimes I
J Clin Endocrinol Metab; 2007 Apr; 92(4):1276-82. PubMed ID: 17213273
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected].
Busiah K; Drunat S; Vaivre-Douret L; Bonnefond A; Simon A; Flechtner I; Gérard B; Pouvreau N; Elie C; Nimri R; De Vries L; Tubiana-Rufi N; Metz C; Bertrand AM; Nivot-Adamiak S; de Kerdanet M; Stuckens C; Jennane F; Souchon PF; Le Tallec C; Désirée C; Pereira S; Dechaume A; Robert JJ; Phillip M; Scharfmann R; Czernichow P; Froguel P; Vaxillaire M; Polak M; Cavé H;
Lancet Diabetes Endocrinol; 2013 Nov; 1(3):199-207. PubMed ID: 24622368
[TBL] [Abstract][Full Text] [Related]
14. Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas.
Dupont J; Pereira C; Medeira A; Duarte R; Ellard S; Sampaio L
J Pediatr Endocrinol Metab; 2012; 25(3-4):367-70. PubMed ID: 22768671
[TBL] [Abstract][Full Text] [Related]
15. DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea.
Cho JH; Kang E; Lee BH; Kim GH; Choi JH; Yoo HW
J Korean Med Sci; 2017 Jun; 32(6):1042-1045. PubMed ID: 28480665
[TBL] [Abstract][Full Text] [Related]
16. Permanent Neonatal Diabetes (DEND Syndrome).
Khan SA; Parkash A; Ibrahim M
J Coll Physicians Surg Pak; 2016 Nov; 26(11):114-115. PubMed ID: 28666500
[TBL] [Abstract][Full Text] [Related]
17. Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation.
Zwaveling-Soonawala N; Hagebeuk EE; Slingerland AS; Ris-Stalpers C; Vulsma T; van Trotsenburg AS
Diabetologia; 2011 Feb; 54(2):469-71. PubMed ID: 21109997
[No Abstract] [Full Text] [Related]
18. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
Jahnavi S; Poovazhagi V; Mohan V; Bodhini D; Raghupathy P; Amutha A; Suresh Kumar P; Adhikari P; Shriraam M; Kaur T; Das AK; Molnes J; Njolstad PR; Unnikrishnan R; Radha V
Clin Genet; 2013 May; 83(5):439-45. PubMed ID: 22831748
[TBL] [Abstract][Full Text] [Related]
19. Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype.
Garcin L; Mericq V; Fauret-Amsellem AL; Cave H; Polak M; Beltrand J
Pediatr Diabetes; 2020 Sep; 21(6):932-941. PubMed ID: 32418263
[TBL] [Abstract][Full Text] [Related]
20. Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene.
Della Manna T; Battistim C; Radonsky V; Savoldelli RD; Damiani D; Kok F; Pearson ER; Ellard S; Hattersley AT; Reis AF
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1350-5. PubMed ID: 19169493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]